Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Vogt Frederick G Interim CEO & General Counsel Exercise or conversion +200,000 $7.55 $1.5M 795,447
2026-11-11 Vogt Frederick G Interim CEO & General Counsel Shares withheld for taxes −191,303 $8.09 $1.5M 604,144
2026-11-11 Vogt Frederick G Interim CEO & General Counsel Exercise or conversion · Stock Option (right to buy) −200,000 0
2026-11-10 Kirby Daniel Gordon Chief Commercial Officer Exercise or conversion +10,000 164,511
2026-11-10 Kirby Daniel Gordon Chief Commercial Officer Shares withheld for taxes −3,935 $8.08 $32K 160,576
2026-11-10 Kirby Daniel Gordon Chief Commercial Officer Exercise or conversion · Restricted Stock Units −10,000 50,003
2026-11-06 Roche Corleen M. Chief Financial Officer Exercise or conversion +12,500 41,257
2026-11-06 Roche Corleen M. Chief Financial Officer Shares withheld for taxes −5,311 $8.04 $43K 35,946
2026-11-06 Roche Corleen M. Chief Financial Officer Exercise or conversion · Restricted Stock Units −12,500 87,505
2026-09-30 Berkowitz Noah Chief Medical Officer Grant or award · Stock Options (Right to Buy) +135,000 135,000
2026-09-30 Berkowitz Noah Chief Medical Officer Grant or award · Restricted Stock Units +180,000 180,000
2026-09-30 Berkowitz Noah Chief Medical Officer Grant or award · Performance Stock Units +135,000 135,000
2026-09-08 Vogt Frederick G Interim CEO & General Counsel Exercise or conversion +15,626 602,085
2026-09-08 Vogt Frederick G Interim CEO & General Counsel Shares withheld for taxes −6,638 $8.70 $58K 595,447
2026-09-08 Vogt Frederick G Interim CEO & General Counsel Exercise or conversion · Restricted Stock Units −15,626 93,756
2026-09-08 BILINSKY IGOR Chief Operating Officer Exercise or conversion +7,813 146,050
2026-09-08 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −3,976 $8.70 $35K 142,074
2026-09-08 BILINSKY IGOR Chief Operating Officer Exercise or conversion · Restricted Stock Units −7,813 46,878
2026-09-08 Puri Raj K. Chief Regulatory Officer Exercise or conversion +9,766 260,842
2026-09-08 Puri Raj K. Chief Regulatory Officer Shares withheld for taxes −4,478 $8.70 $39K 256,364

Page 1 of 31 · 605 trades